Latest news with #Grisanti
CNBC
01-05-2025
- Business
- CNBC
These two health-care names work in a 'difficult' market, says MAI Capital Management strategist
In this volatile environment, there could be big opportunities in two health-care names, according to Chris Grisanti, MAI Capital Management's chief market strategist. Stocks have been rocky amid fears about President Donald Trump' s high-tariff policy and the economy. On Thursday, equities moved up again after investors reacted to strong earnings from two tech titans, Meta Platforms and Microsoft , out after the bell Wednesday. Grisanti said his health-care plays will work best "when the market gets more difficult again." He gave his two buys, and one name he's avoiding, during the " Three Stock Lunch " segment on CNBC's " Power Lunch " Tuesday. AbbVie The global biopharmaceutical company has done a great job of replacing its blockbuster anti-inflammatory drug Humira, which has faced declining sales since it lost patent protection in 2023, Grisanti said. AbbVie now has two new drugs, Skyrizi and Rinvoq. The company posted first-quarter earnings and revenue last week that topped Street expectations. It also raised its full-year earnings-per-share guidance. AbbVie also announced in February it will invest at least $10 billion in manufacturing in the United States, including four new plants. "They've got a great management [team] there," Grisanti said. "They're mixing up the product line and so that should be real strong." ABBV YTD mountain AbbVie While shares have moved higher in recent days, they still have "a ways to go," he said. The stock lost nearly 7% in April. It is up more than 9% year to date and has a dividend yield of 3.36% UnitedHealth UnitedHealth Group is currently "in the penalty box, for good reason," Grisanti said. Shares have been pummeled since mid-April, when the health-care provider cut its annual profit forecast due to higher-than-expected medical costs. The stock hit a 52-week low on Thursday and is down more than 20% year to date. It has a 2.04% dividend yield. "This is a very rare chance to get this stock, which has great management, terrific 20-year growth profile, at a cheap valuation," Grisanti said. Booking Holdings The last name on Grisanti's list is one that he would not recommend right now: Booking Holdings . The online travel booking provider beat on both the top and bottom lines when it reported first-quarter results on Tuesday. Its gross bookings narrowly topped expectations. However, tariffs are going to start hitting corporate earnings this summer, Grisanti said. "Travel is about the most discretionary category we have," he said. "It's a great company, but I don't want to be owning it if we're sliding towards a recession." Shares are up 3% so far this year.
Yahoo
08-04-2025
- Health
- Yahoo
As measles cases rise, health experts urge vaccinations
BUFFALO, N.Y. (WIVB) — Cases of measles have been confirmed as close as Ontario, Canada. Local health experts are concerned it's only a matter of time before someone in Western New York contracts the virus. 'Measles is the canary in the coal mine. It's so infectious that if we have pockets of individuals that aren't vaccinated, or have those lower rates of vaccination, it spreads quite readily,' said Dr. Thomas Russo, SUNY distinguished professor and infectious disease expert at the Jacobs School of Medicine and Biomedical Sciences. Russo stressed the importance and effectiveness of the MMR vaccine. 'Vaccination does a great job in preventing against infection, but if we have unvaccinated individuals or vaccination rates drop below a 95 percent level, we're going to see infections,' Russo said. 'Unfortunately that's what's occurring right now in certain parts of the country.' Health experts say the measles vaccine is 93% effective with the first dose and 97% effective with the second. 'It's found to be a very safe and effective method to protect children from a potentially deadly disease and it's really sad that we're seeing in this century a disease that had been eradicated coming back and causing death in children,' said Dr. Kathleen Grisanti, president and medical director at the Pediatric & Adolescent Urgent Care of WNY. Grisanti's Orchard Park location already has procedures in place if a patient shows symptoms. 'We put precautions in place so if a parent brings a child in with a generalized rash and fever, we ask them to wait in the car until it's time for them to be put into a room. We mask up and take precautions for our staff,' Grisanti said. She said it's alarming that hundreds of measles cases have been confirmed just a short distance from Western New York. 'It's very alarming that there's so many cases in Canada,' Grisanti said. 'With the majority of the cases, over 650 cases, in Ontario, we feel it's only a matter of time before it's going to infiltrate in the Buffalo region.' Local health experts urge parents to get their children vaccinated and talk to their children's pediatrician. Sarah Minkewicz is an Emmy-nominated reporter and Buffalo native who has been a part of the News 4 team since 2019. Follow Sarah on Twitter @SarahMinkewicz and click here to see more of her work. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
17-03-2025
- Business
- Yahoo
Is MetLife, Inc. (NYSE:MET) a Top Extreme Value Stock to Invest in Right Now?
We recently published a list of Top 12 Extreme Value Stocks to Invest In Right Now. In this article, we are going to take a look at where MetLife, Inc. (NYSE:MET) stands against other top extreme value stocks to invest in right now. On March 11, Chris Grisanti, MAI Capital Management chief market strategist, joined CNBC for an interview to talk about the recent developments in the market. He noted that the growth stocks tend to go up and down really quickly, what a lot of investors miss while investing is that along with choosing a good company you also have to choose a good entry price. This has been the case for the last 7 years as the valuations have gotten out of control as the growth stocks have largely outperformed value stocks. Grisanti believes that now the market is going back to the point where the value stocks will take over the growth sector. Grisanti thinks something different is happening in terms of the current market slowdown. He does not think that this downturn is due to over exuberance. Grisanti explained that over the past years the norm has been that the tech stocks get ahead and later pull the market down a bit towards a natural and healthier price correction. This is different as per the chief market strategist, currently there are economically sensitive stocks leading the way down. We have banks, airlines, financials, and the industrials tanking. He pointed out that this is the first time in 3 years that the market is telling the fears of an economic slowdown. Moreover, Grisanti further explained that usually the market can fall on irrational fears however become self fulfilling automatically. However, the current slowdown seems different from the usual scenarios. Through the first two months of 2025, the market has been mediocre and the Mag Seven were down slightly. However, the banks were up high single digits and the airlines were also up. Now, it has all turned around, tech continues to go down and has been joined by the economically sensitive sectors as well, which is a 'Yellow Signal' for the market. Grisanti likes stocks that are trading cheaper than the market and he thinks it is not a bad time to start selecting companies that are cheap and can meet the earnings expectations. To curate the list of top 12 extreme value stocks to invest in right now, we used the Finviz stock screener, Seeking Alpha, and Yahoo Finance as our sources. Using the screener we aggregated a list of value stocks trading between a forward P/E of 5 t0 10, with earnings expected to grow in the current and next year. Next, after sorting the list by market capitalization we cross checked the forward P/E of each stock from Seeking Alpha and expected earnings growth from Yahoo Finance. Lastly, we ranked the list in ascending order of the number of hedge fund holders, as of Q4 2024. Please note that the data was recorded on March 12, 2025. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). An expert in the field of finance researching new markets and investment opportunities. MetLife, Inc. (NYSE:MET) is an international financial services company that provides insurance, annuities, employee benefits, and asset management services to individual and institutional clients. The company operates in over 60 countries through several business segments including Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe, the Middle East, and Africa, and MetLife Holdings segment. On February 6, Analyst Suneet Kamath from Jefferies reiterated a Buy rating on the stock with a price target of $104. The analyst's positive outlook for the company is supported by its recovery in Q4 2024 and its commitment to double-digit EPS growth and a 15% to 17% return on equity. Kamath anticipates positive contributions from the Group Benefits and Retirement & Income Solutions segments, noting stable financial metrics like capital position and free cash flow conversion. During the fiscal fourth quarter of 2024, MetLife, Inc. (NYSE:MET) premiums, fees, and other revenues increased to $14.5 billion, reflecting a 6% increase year-over-year. Moreover, net investment income rose to $5.4 billion, up 1% from Q4 2023, driven by higher variable investment income. It is one of the top extreme-value stocks to invest in right now. Overall, MET ranks 4th on our list of top extreme value stocks to invest in right now. While we acknowledge the potential of MET as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MET but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
05-03-2025
- Business
- Yahoo
Stagflation fears rise as a brutal jobs report follows new tariffs
The odds of the economy slowing while inflation stays fast — stagflation — may be increasing as a new survey showed that U.S. employers drastically curtailed their hiring last month to the slowest pace since July. Other recent data have pointed toward a weakening labor market, including unemployment claims and the ISM manufacturing survey — which also showed a big jump in prices paid. January CPI came in hot. And the Atlanta fed is now projecting a 2.8% contraction in the U.S. economy this quarter. While the Federal Reserve would normally cut interest rates to help buoy growth, that option may not be available if inflation remains high, creating a dilemma for policymakers. Additionally, the Fed can't use a rate hike to counteract the price shock from the sudden jump in tariffs. 'The Fed won't make the mistake' of racing in to save the day with a rate cut, Explosive Options' founder Bob Lang said last week. 'Inflation is still way too sticky. The bond market is telling you that there isn't room to cut. The specter of deflation is back.' Today's ADP Research (ADP) report showed that private-sector firms took on 77,000 workers in February, down from 186,000 in January and just above half the level that economists had estimated, according to a FactSet (FDS) survey. The tech, education and health services, and trade and transportation sectors lost jobs. This data is likely to be followed by a weak official jobs report on Friday, Chris Grisanti, chief market strategist at MAI Capital Management, told Quartz yesterday. While the consensus estimate calls for a bigger rise in payrolls last month than the 143,000 in January, Grisanti expects about 110,000, possibly even below 100,000. Investors often treat bad news as good news because it increases the odds that the Fed will cut rates, but this changes if they feel the economy is actually slowing, Grisanti said. Yesterday's trading pattern, where banks and industrials fell while tech bounced, reflected real concern about U.S. growth. 'Sometimes bad news is bad news,' Grisanti said. 'Tariffs could be hastening the inevitable decline you get at the top of markets as the economy is beginning to slow. [Donald] Trump just had the bad luck to be elected president at the top of the business cycle.' Not all the data is down-arrow: The ISM Services index for February came in higher than expected today at 53.5, comfortably in expansionary territory. Stocks rose, with Dow Jones Industrial average up 177 points, and the S&P 500 and Nasdaq Composite both showing modest gains. For the latest news, Facebook, Twitter and Instagram.
